-
Global honeybee populations have been declining for many years, due to disease, loss of habitat and poor beekeeping practices. A newly approved vaccine helps fight American Foulbrood disease.
-
Last school year marked a more than 10-year low for Florida’s kindergarten and seventh-grade students completing all doses of required immunizations, according to a recent report from the state Department of Health. The required shots — which do not include COVID-19 vaccinations — are designed to protect against diseases including tetanus, diphtheria, measles, mumps, rubella, influenza B, hepatitis B and polio.
-
Pfizer reported preliminary results of its pregnancy vaccine, a shot it also tested successfully in older adults. Rival GSK also has reported success with its vaccine version in seniors.
-
A CDC committee voted that the agency should update its recommended immunization schedules to add the COVID vaccine, including to the schedule for children. However, that doesn't mandate the vaccine for schoolchildren.
-
Biden's comments — made as officials try to convince Americans to get a new booster shot and the White House seeks $22 billion in new COVID funding — were "unfortunate," several epidemiologists said.
-
The U.S. Food and Drug Administration authorized on Wednesday an updated formula of the COVID-19 vaccine made by Pfizer and rival Moderna, which target today’s most common omicron strain.
-
In a Georgia city that is home to many refugees, the vaccination rate is higher than in the state, county, and surrounding communities of similar socioeconomic status.
-
The two-dose vaccine uses a protein-based technology, unlike the mRNA approach used in vaccines made by Pfizer and Moderna. CDC approval is still needed for ages 12-17.
-
Dr. Simone Gold was issued a medical license from the state department of health and has opened an online practice based in Naples.
-
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
-
The Biden administration is allowing the shot to be given between layers of skin — a method that only requires a fifth of the full dose — in order to increase vaccinations and slow the outbreak.
-
There isn't currently a Lyme disease vaccine on the U.S. market. Researchers are hoping to change that.